Physicochemical properties of novel protein kinase inhibitors in relation to their substrate specificity for drug transporters

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Opinion on Drug Metabolism & Toxicology

• Publication date

  2015-05-04

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1517/17425255.2015.1006626PMID 25633410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PDZK1 and NHERF1 Regulate the Function of Human Organic Anion Transporting Polypeptide 1A2 (OATP1A2) by Modulating Its Subcellular Trafficking and Stability

  2014cited by this paper
• Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?

  2014cited by this paper
• A cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells.

  2013cited by this paper
• Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide

  2013influential reference
• How to improve exposure of tumor cells to drugs: promoter drugs increase tumor uptake and penetration of effector drugs.

  2012cited by this paper
• Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel

  2012cited by this paper
• Regulation of Tissue-Specific Expression of Renal Organic Anion Transporters by Hepatocyte Nuclear Factor 1 α/β and DNA Methylation

  2012cited by this paper
• Structural approaches to obtain kinase selectivity.

  2012cited by this paper
• Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance

  2012cited by this paper
• OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies

  2012cited by this paper
• Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics

  2012cited by this paper
• Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells.

  2012cited by this paper
• Improving drug penetration to curb tumor drug resistance.

  2012cited by this paper
• Nilotinib and imatinib inhibit cytarabine cellular uptake: implications for combination therapy.

  2012cited by this paper
• Interactions of Tyrosine Kinase Inhibitors with Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Proteins

  2011influential reference
• PDZK1 binding and serine phosphorylation regulate subcellular trafficking of organic anion transport protein 1a1.

  2011cited by this paper
• Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2

  2011cited by this paper
• Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissue

  2011cited by this paper
• Regulation of drug transporter mRNA expression by interferon‐γ in primary human hepatocytes

  2011cited by this paper
• Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

  2011cited by this paper
• Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia.

  2011cited by this paper
• Environmental and Genetic Factors Affecting Transport of Imatinib by OATP1A2

  2011cited by this paper
• Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation

  2010cited by this paper
• Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism

  2010cited by this paper
• Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization*

  2010cited by this paper
• The Human Organic Anion Transporter Genes OAT5 and OAT7 Are Transactivated by Hepatocyte Nuclear Factor-1α (HNF-1α)

  2010cited by this paper
• In Vitro to In Vivo Comparison of the Substrate Characteristics of Sorafenib Tosylate toward P-Glycoprotein

  2010cited by this paper
• Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines.

  2010cited by this paper
• Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters

  2009cited by this paper
• Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters

  2009cited by this paper
• Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

  2009cited by this paper
• Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol

  2009cited by this paper
• Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts.

  2009cited by this paper
• Differential Regulation of Drug Transporter Expression by Hepatocyte Growth Factor in Primary Human Hepatocytes

  2009cited by this paper
• Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia

  2009cited by this paper
• Expression of human organic cation transporter 3 in kidney carcinoma cell lines increases chemosensitivity to melphalan, irinotecan, and vincristine.

  2009influential reference
• Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters.

  2009cited by this paper
• Organic Anion-Transporting Polypeptide 1B1 Mediates Transport of Gimatecan and BNP1350 and Can Be Inhibited by Several Classic ATP-Binding Cassette (ABC) B1 and/or ABCG2 Inhibitors

  2009cited by this paper
• The Role of Efflux and Uptake Transporters in N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, Lapatinib) Disposition and Drug Interactions

  2008cited by this paper
• Organic Anion Transporter OAT1 Undergoes Constitutive and Protein Kinase C-regulated Trafficking through a Dynamin- and Clathrin-dependent Pathway*

  2008cited by this paper
• Interaction of Cisplatin with the Human Organic Cation Transporter 2

  2008influential reference
• Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications

  2008cited by this paper
• Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma

  2008cited by this paper
• Imatinib inhibition of fludarabine uptake in T-lymphocytes

  2008cited by this paper
• Interaction of Imatinib with Human Organic Ion Carriers

  2008cited by this paper
• Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices.

  2008cited by this paper
• Down-Regulation of Organic Anion Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokine Interleukin 1β

  2008cited by this paper
• ABC multidrug transporters: structure, function and role in chemoresistance.

  2008cited by this paper
• Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia.

  2008cited by this paper
• Transcriptional Regulation of Human and Mouse Organic Anion Transporter 1 by Hepatocyte Nuclear Factor 1 α/β

  2008cited by this paper
• Regulation of Prostaglandin Transporters in Colorectal Neoplasia

  2008cited by this paper
• Imatinib-Resistant CML Cells Have Low ENT Activity But Maintain Sensitivity to Gemcitabine

  2008cited by this paper
• Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.

  2008cited by this paper
• Expression of the Uptake Drug Transporter hOCT1 is an Important Clinical Determinant of the Response to Imatinib in Chronic Myeloid Leukemia

  2008cited by this paper
• Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans

  2007cited by this paper
• Hepatocyte Nuclear Factor 1 Alpha is a Factor Responsible for the Interindividual Variation of OATP1B1 mRNA Levels in Adult Japanese Livers

  2007cited by this paper
• Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications

  2007cited by this paper
• Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells

  2007cited by this paper
• Human liver‐specific organic anion transporter‐2 is a potent prognostic factor for human breast carcinoma

  2007cited by this paper
• Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation.

  2007cited by this paper
• Regulation of Tissue-Specific Expression of the Human and Mouse Urate Transporter 1 Gene by Hepatocyte Nuclear Factor 1 α/β and DNA Methylation

  2007cited by this paper
• The Influence of Macrolide Antibiotics on the Uptake of Organic Anions and Drugs Mediated by OATP1B1 and OATP1B3

  2007cited by this paper
• Elimination of Organic Anions in Response to an Early Stage of Renal Ischemia-Reperfusion in the Rat: Role of Basolateral Plasma Membrane Transporters and Cortical Renal Blood Flow

  2007cited by this paper
• Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.

  2006cited by this paper
• OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib.

  2006cited by this paper
• Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3 Published, JLR Papers in Press, March 13, 2006.

  2006cited by this paper
• Optimizing the "drug-like" properties of leads in drug discovery

  2006cited by this paper
• Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family)

  2006cited by this paper
• Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics

  2006cited by this paper
• Organic cation transporters are determinants of oxaliplatin cytotoxicity.

  2006cited by this paper
• Combining multiple microarrays in the presence of controlling variables

  2006cited by this paper
• Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery.

  2006cited by this paper
• Regulation of the Expression of Human Organic Anion Transporter 3 by Hepatocyte Nuclear Factor 1α/β and DNA Methylation

  2006cited by this paper
• Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha.

  2006cited by this paper
• Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation.

  2006cited by this paper
• The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α

  2006cited by this paper
• Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells

  2005cited by this paper
• ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier.

  2005cited by this paper
• Suppression of Cell Proliferation by Inhibition of Estrone-3-Sulfate Transporter in Estrogen-Dependent Breast Cancer Cells

  2005cited by this paper
• Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation.

  2005cited by this paper
• Co-localization and interaction of organic anion transporter 1 with caveolin-2 in rat kidney

  2005cited by this paper
• The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α and Suppressed by Bile Acids

  2005cited by this paper
• Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel

  2005cited by this paper
• Mucins in cancer: protection and control of the cell surface

  2004cited by this paper
• Regulation of the human organic cation transporter hOCT1

  2004cited by this paper
• Active transport of imatinib into and out of cells: implications for drug resistance.

  2004influential reference
• The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma.

  2004cited by this paper
• Involvement of Estrone-3-Sulfate Transporters in Proliferation of Hormone-Dependent Breast Cancer Cells

  2004cited by this paper
• Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588

  2004cited by this paper
• Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney.

  2004cited by this paper
• Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases.

  2003cited by this paper
• Hepatocyte nuclear factor 1α: A key mediator of the effect of bile acids on gene expression

  2003cited by this paper
• Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization.

  2003influential reference
• Inhibition of Nucleoside Transport by Protein Kinase Inhibitors

  2003cited by this paper
• MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models.

  2003cited by this paper
• Detection of the Human Organic Anion Transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in Liver and Hepatocellular Carcinoma

  2003cited by this paper
• Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.

  2003cited by this paper
• The Organic Cation Transporters rOCT1 and hOCT2 Are Inhibited by cGMP

  2002cited by this paper
• Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes : A transcriptional control of a plausible bile acid transporter

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper

• Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs.

  2026cites this paper
• The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of Tyrosine Kinase Inhibitors

  2023influential citation
• Involvement of Transporters in Intestinal Drug–Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time

  2022cites this paper
• Impact of gastrointestinal physiology on drug absorption in special populations - An UNGAP review.

  2020cites this paper
• Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

  2020influential citation
• Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance

  2020cites this paper
• An intact C-terminal end of albumin is required for its long half-life in humans

  2020cites this paper
• Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors

  2020cites this paper
• Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems

  2019cites this paper
• Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles.

  2019cites this paper
• Resistance to crizotinib in a cMET gene amplified tumor cell line is associated with impaired sequestration of crizotinib in lysosomes

  2018cites this paper
• Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group

  2018cites this paper
• Cancer drug resistance: a new perspective

  2018cites this paper
• Subcellular localization of several structurally different tyrosine kinase inhibitors

  2018cites this paper
• Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance

  2018cites this paper
• The potential of multi-compound nanoparticles to bypass drug resistance in cancer

  2017cites this paper
• Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib

  2016cites this paper
• Mechanistic and Pharmacological Insights into Modulation of ABC Drug Transporters by Tyrosine Kinase Inhibitors

  2016cites this paper
• Dye-Sensitized and Localized Surface Plasmon Resonance Enhanced Visible-Light Photoelectrochemical Biosensors for Highly Sensitive Analysis of Protein Kinase Activity.

  2016cites this paper
• Transport of six tyrosine kinase inhibitors: active or passive ?

  2016cites this paper
• Drug transport and metabolism of novel anticancer drugs

  2015cites this paper
• NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor

  2015cites this paper